FRM
Fox Run Management’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-53,141
| Closed | -$1.46M | – | 1068 |
|
|
2024
Q3 | $1.46M | Buy |
+53,141
| New | +$1.46M | 0.32% | 36 |
|
|
2024
Q2 | – | Sell |
-17,120
| Closed | -$365K | – | 967 |
|
|
2024
Q1 | $365K | Buy |
+17,120
| New | +$365K | 0.08% | 470 |
|
|
2019
Q1 | – | Sell |
-25,703
| Closed | -$747K | – | 617 |
|
|
2018
Q4 | $747K | Buy |
25,703
+18,027
| +235% | +$524K | 0.4% | 30 |
|
|
2018
Q3 | $353K | Sell |
7,676
-16,555
| -68% | -$761K | 0.15% | 296 |
|
|
2018
Q2 | $906K | Buy |
+24,231
| New | +$906K | 0.29% | 50 |
|
|
2017
Q2 | – | Sell |
-18,268
| Closed | -$351K | – | 756 |
|
|
2017
Q1 | $351K | Buy |
18,268
+1,168
| +7% | +$22.4K | 0.14% | 312 |
|
|
2016
Q4 | $285K | Buy |
+17,100
| New | +$285K | 0.15% | 316 |
|
|
2016
Q3 | – | Sell |
-12,800
| Closed | -$392K | – | 614 |
|
|
2016
Q2 | $392K | Sell |
12,800
-6,700
| -34% | -$205K | 0.19% | 191 |
|
|
2016
Q1 | $730K | Buy |
+19,500
| New | +$730K | 0.49% | 24 |
|